Skip to content
MediHelp
MediHelp Drug reference

Drug interactions

Anti-thymocyte + Basiliximab

Severity: Major

Anti-thymocyte and Basiliximab: major interaction.

Last updated Sources: UK SmPC

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents target T-cell function, and using them together provides excessive immunosuppression. This increases the risk of infection and possibly malignancy, and they are generally not used as combined induction.

What this interaction means in plain words

Anti-thymocyte and Basiliximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Anti-thymocyte belongs to Miscellaneous; Basiliximab belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Additive T-cell directed immunosuppression (depletion plus IL-2 receptor blockade).

What to do

Avoid using both for induction; choose one agent. If sequential use occurs, monitor for infection and give appropriate prophylaxis.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anti-thymocyte and Basiliximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription
Create free account Sign in

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Anti-thymocyte with Basiliximab?

MediHelp rates the interaction as major. Anti-thymocyte and Basiliximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents target T-cell function, and using them together provides excessive immunosuppression. This increases the risk of infection and possibly malignancy, and they are generally not used as combined induction.

How serious is the interaction between Anti-thymocyte and Basiliximab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using both for induction; choose one agent. If sequential use occurs, monitor for infection and give appropriate prophylaxis.

What other medicines interact with Anti-thymocyte?

MediHelp also lists interactions of Anti-thymocyte with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Anti-thymocyte page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Download on theApp Store Get it onGoogle Play

Browse A–Z · Drug interactions

Get the app Sign in